Description

This issue of Vital Signs, released on May 1, 2006, provides a strategic overview of the possible impact of Medical Tourism on the U.S. Healthcare system and markets. Additionally, a company profile is provided on CoAxia, a company dedicated to the development of next generation technology in the treatment of cerebral ischemia due to stroke or vasospasms. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of April 17 - 21, 2006.